Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 0228-3060

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate (NDC 0228-3060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6df967f2-figure-01 (Image 1)

6df967f2-figure-01 (Image 1)
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended release capsules, 5 mg strength. The amber capsule with green and yellow imprint displays the number 5. This oral capsule is labeled by Actavis Pharma, Inc.*
FDA Label Image

6df967f2-figure-10 (Image 10)

6df967f2-figure-10 (Image 10)
Extended-release capsule blister pack for Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate, showing capsules in a 30-count layout. Each capsule is imprinted with number 10 and shaded in a pink and purple color scheme.*
FDA Label Image

6df967f2-figure-11 (Image 11)

6df967f2-figure-11 (Image 11)
The image shows a carton for Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules. The package displays the labeler Actavis Pharma, Inc., and a quantity of 100 capsules is visible. Specific strength is not legible from the image.*
FDA Label Image

6df967f2-figure-12 (Image 12)

6df967f2-figure-12 (Image 12)
Packaging label for Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release capsules. The label shows 7.5 mg strength with green cap and white body capsules. Manufactured by Actavis Pharma, Inc. The capsules have imprint 'A 7.5' in black.*
FDA Label Image

6df967f2-figure-13 (Image 13)

6df967f2-figure-13 (Image 13)
The image shows a carton of Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release capsules. It includes multiple dosage strengths (1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 6.25 mg, and 7.5 mg) for oral use. The labeler is Actavis Pharma, Inc., and the carton contains 100 capsules.*
FDA Label Image

1 (Image 14)

1 (Image 14)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules, 5 mg strength. The label indicates it contains 100 capsules, is Rx only, and is manufactured by Actavis Pharma, Inc. It includes medication guide instructions and storage information. The label shows detailed ingredient strengths per capsule and has NDC 0228-3062-11 with a barcode.*
FDA Label Image

1 (Image 15)

1 (Image 15)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules 10 mg by Actavis Pharma, Inc. The label shows dosage strength, dosing components, quantity of 100 capsules, storage instructions, and manufacturer information.*
FDA Label Image

1 (Image 16)

1 (Image 16)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules 15 mg by Actavis Pharma, Inc. The label indicates 100 capsules in the package, prescription only. It includes dosing information, storage instructions, and a barcode with serialization coding area on the right side.*
FDA Label Image

1 (Image 17)

1 (Image 17)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules 20 mg. The label indicates a 100-count prescription package from Actavis Pharma, Inc., with detailed active ingredient strengths per capsule and instructions for storage and dispensing. The label includes medication guide and serialization coding information.*
FDA Label Image

1 (Image 18)

1 (Image 18)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules 25 mg by Actavis Pharma, Inc. The package contains 100 capsules, indicated for prescription use only. The label includes dosage details, storage instructions, and manufacturer information from Teva Pharmaceuticals.*
FDA Label Image

1 (Image 19)

1 (Image 19)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules, 30 mg strength. The label indicates 100 capsules in the package and is manufactured by Actavis Pharma, Inc. It includes dispensing instructions, active ingredient quantities per capsule, storage conditions, and a barcode with NDC 0228-3061-11.*
FDA Label Image

6df967f2-figure-02 (Image 2)

6df967f2-figure-02 (Image 2)
Packaging label for Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended release capsules, 3.75 mg strength. The label shows a white capsule bottle with a child-resistant cap, containing 100 capsules. The product is labeled for oral use and is manufactured by Actavis Pharma, Inc.*
FDA Label Image

6df967f2-figure-03 (Image 3)

6df967f2-figure-03 (Image 3)
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release capsules in a 100-count bottle from Actavis Pharma, Inc. The white plastic bottle has a white child-resistant cap and a label featuring the product name, dosage form, and strength with the labeler information.*
FDA Label Image

6df967f2-figure-04 (Image 4)

6df967f2-figure-04 (Image 4)
Packaging label for extended-release capsules of Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate. The label shows the proprietary and generic names. The labeler is Actavis Pharma, Inc. The label displays capsule strength and details indicating the content is for oral administration.*
FDA Label Image

6df967f2-figure-05 (Image 5)

6df967f2-figure-05 (Image 5)
Packaging label for extended release capsules containing Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. The label shows the proprietary name, dosage form as extended release capsules, strength as 7.5 mg, and the labeler as Actavis Pharma, Inc. The package contains 30 capsules.*
FDA Label Image

6df967f2-figure-06 (Image 6)

6df967f2-figure-06 (Image 6)
Packaging label of Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release capsules, showing six blister cards each containing 30 capsules. The capsules are yellow and white, with printed alphanumeric codes on them. The label indicates the product is manufactured by Actavis Pharma, Inc.*
FDA Label Image

1 (Image 7)

1 (Image 7)
A line graph showing mean plasma concentrations of dextroamphetamine and levoamphetamine (ng/mL) over 24 hours. The graph compares extended-release and immediate-release formulations of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate at 20 mg qd and 10 mg bid doses. Different symbols represent each formulation and release type for both dextroamphetamine and levoamphetamine concentrations.*
FDA Label Image

6df967f2-figure-08 (Image 8)

6df967f2-figure-08 (Image 8)
Packaging label of Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release capsules. The label shows capsules with a red and white cap and a blue body imprinted with 'ADDERALL XR 15 mg.' The product is manufactured and labeled by Actavis Pharma, Inc.*
FDA Label Image

6df967f2-figure-09 (Image 9)

6df967f2-figure-09 (Image 9)
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate 5 mg extended release capsules. The blister pack contains 25 capsules arranged in rows. Each capsule is two-toned, with one half white and the other half orange, with black imprinting on the orange side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.